Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells.
第一作者:
Yuji,Sakuma
第一单位:
1] Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan [2] Laboratory for Molecular Diagnostics, Kanagawa Cancer Center Hospital, Yokohama, Japan [3] Department of Pathology, Jichi Medical University, Tochigi, Japan.
作者:
医学主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);自噬(Autophagy);细胞低氧(Cell Hypoxia);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);上皮-间质转化(Epithelial-Mesenchymal Transition);女(雌)性(Female);人类(Humans);肺(Lung);肺肿瘤(Lung Neoplasms);男(雄)性(Male);微管相关蛋白质类(Microtubule-Associated Proteins);突变蛋白质类(Mutant Proteins);肿瘤蛋白质类(Neoplasm Proteins);吞噬体(Phagosomes);蛋白激酶抑制剂(Protein Kinase Inhibitors);RNA干扰(RNA Interference)
DOI
10.1038/labinvest.2013.102
PMID
23938604
发布时间
2023-02-16
- 浏览48
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



